New York, NY – February 2, 2026 – LedgerDomain, a leader in secure digital identity and credentialing for the healthcare supply chain, has been implemented by Memorial Sloan Kettering Cancer Center (MSK) to help satisfy every requirement of the federal Drug Supply Chain Security Act (DSCSA), the 2013 law designed to ensure prescription drugs are tracked and verified across the supply chain.
Cancer centers like MSK operate a vast, complex network of pharmacies including hospital, specialty, infusion, and research dispensaries, handling thousands of cancer therapies each day. LedgerDomain’s XATP solution is designed to verify and trace every package of medication, securely credential suppliers and wholesalers, report suspect products, and align data records.
“For those who get tired of waiting in line, credentials serve as the universal ‘TSA PreCheck’ where every participant and connection is continuously validated and secured,” said Ben Taylor, CEO of LedgerDomain. “Our goal is to close every gap in the drug supply chain and keep patients safe, while keeping the administrative burden on MSK at a minimum.”
This announcement comes as pharmacies and health systems around the country are intensifying efforts to comply with DSCSA’s final rules, which are now in effect for all manufacturers, wholesalers, and large dispensers across the U.S.
